GlassScriptPhysician profile
Amy Xu
NPI 1073162269
$516.86
in general payments reported to CMS, 2019-2025
12 companies · $161 in 2025
The $161 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $58.70 · 2023: $165 · 2024: $132 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $89.26 | 2024-2025 | |
| Tactile Systems Technology INC | $78.87 | 2023 | Flexitouch Plus, Entre Plus |
| Smith+Nephew, INC. | $71.09 | 2025 | Collagenase Santyl |
| Solventum Corporation | $64.11 | 2024-2025 | V.A.C. Veraflo Cleanse Choice, V.A.C. Granufoam, Prevena |
| Medtronic, INC. | $58.70 | 2022 | |
| Terumo Medical Corporation | $35.01 | 2024 | Glidesheath Slender, Angio-Seal |
| Cardiva Medical, INC. | $34.60 | 2023 | Cardiva Vascade 5f Vcs |
| Janssen Pharmaceuticals, INC | $20.38 | 2023 | Xarelto |
| Organogenesis INC. | $19.88 | 2025 | Puraply Wound Matrix |
| Abbott Laboratories | $19.55 | 2023 | Diamondback Peripheral |
| Melinta Therapeutics, LLC | $13.67 | 2024 | Orbactiv, Kimyrsa |
| Cardiovascular Systems INC. | $11.74 | 2023 | Diamondback Peripheral |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Xu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.